MONTREAL, QUEBEC--(CCNMatthews - Oct. 30, 2006) - Ambrilia Biopharma Inc.(TSX:AMB), a biopharmaceutical company developing innovative therapeutics in the fields of oncology and infectious diseases, announced today that it's President and Chief Executive Officer, Hans J. Mader, will present an overview of the Company's latest developments at the Rodman & Renshaw 8th Annual Healthcare Conference to be held in New-York, November 6-8. This presentation will take place on Monday, November 6, at 9:10 a.m. local time, in Kennedy I room.
